Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non‐small cell lung cancer

Background The prognostic significance of non‐cancer‐related prognostic factors, such as body composition, has gained extensive attention in oncological research. Compared with sarcopenia, the prognostic significance of adipose tissue for overall survival in non‐small cell lung cancer remains unclea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Cachexia, Sarcopenia and Muscle Sarcopenia and Muscle, 2023-12, Vol.14 (6), p.2591-2601
Hauptverfasser: Tao, Junli, Fang, Jiayang, Chen, Lihua, Liang, Changyu, Chen, Bohui, Wang, Zhenyu, Wu, Yongzhong, Zhang, Jiuquan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The prognostic significance of non‐cancer‐related prognostic factors, such as body composition, has gained extensive attention in oncological research. Compared with sarcopenia, the prognostic significance of adipose tissue for overall survival in non‐small cell lung cancer remains unclear. We investigated the prognostic value of skeletal muscle and adipose tissue in patients with non‐small cell lung cancer. Methods This retrospective study included 4434 patients diagnosed with non‐small cell lung cancer between January 2014 and December 2016. Cross‐sectional areas of skeletal muscle and subcutaneous fat were measured, and the pericardial fat volume was automatically calculated. The skeletal muscle index and subcutaneous fat index were calculated as skeletal muscle area and subcutaneous fat area divided by height squared, respectively, and the pericardial fat index was calculated as pericardial fat volume divided by body surface area. The association between body composition and outcomes was evaluated using Cox proportional hazards model. Results A total of 750 patients (501 males [66.8%] and 249 females [33.2%]; mean age, 60.9 ± 9.8 years) were included. Sarcopenia (60.8% vs. 52.7%; P 
ISSN:2190-5991
2190-6009
DOI:10.1002/jcsm.13333